For the past 70 years, Institut Rosell-Lallemand has been committed to continuous innovation. In 1998, the acquisition of Institut Rosell by Lallemand Group Inc. paved the way to exciting new possibilities in the area of research henceforth focused on the scientific and clinical documentation of probiotic formulations designed specifically for their health benefits.
Dedicated to continuously improving scientific performance, Institut Rosell-Lallemand has forged numerous collaborative relationships with public and private partners, which include Canadian universities (McGill University, Université de Montréal, Université Laval), pharmaceutical laboratories and world-renowned research centres located primarily in North America and Europe. The fundamental purpose of these affiliations is to bring the best expertise to its strains and finished products in the areas of strain grading, pharmacological and action mode analysis, toxicological assessment, pre-clinical and clinical trials, and pharmacokinetics.
CanadaHospital for Sick Children, Toronto, ONMcMaster Hospital, Hamilton, ON Université Laval-INAF, Quebec, QC Agriculture-Agrifood Canada, Lennoxville, QC CRDA Sainte Hyacinthe, QC McGill University and Genome Quebec, Montreal Hopital Sacre Coeur, Montreal, QC University of New Brunswick, Moncton, NB USAUniversity of Florida, Gainesville, FLUtah State University, Logan, UT University of Wisconsin-Madison, WI FranceINRA ToulouseINRA Jouy en Josas Université Paul Sabatier Toulouse CHU Rouen Hopital Louis Mourier Colombes (92) |
UKNottingham UniversityAustraliaUniversity of New South WalesPolandMedical Academy, LodzMedical Academy, Warsaw University College of Medecine, Krakow Czech RepublicThomeyer Hospital, PragueFaculty Hospital Prague Motol UkraineGovernment Medical University, ZaporozhyeUNAS, Kiev |
